SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-067982
Filing Date
2020-06-01
Accepted
2020-06-01 07:08:14
Documents
37
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014552-1_10q.htm 10-Q 350465
2 EXHIBIT 31.1 tm2014552d1_ex31-1.htm EX-31.1 10080
3 EXHIBIT 31.2 tm2014552d1_ex31-2.htm EX-31.2 10275
4 EXHIBIT 32.1 tm2014552d1_ex32-1.htm EX-32.1 4787
5 EXHIBIT 32.2 tm2014552d1_ex32-2.htm EX-32.2 4517
12 GRAPHIC tm2014552-1_10qimg01.jpg GRAPHIC 30012
13 GRAPHIC tm2014552-1_10qimg02.jpg GRAPHIC 40196
  Complete submission text file 0001104659-20-067982.txt   1847555

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plx-20200331.xml EX-101.INS 242335
7 XBRL TAXONOMY EXTENSION SCHEMA plx-20200331.xsd EX-101.SCH 22705
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20200331_cal.xml EX-101.CAL 30490
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20200331_def.xml EX-101.DEF 65022
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20200331_lab.xml EX-101.LAB 168948
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20200331_pre.xml EX-101.PRE 139100
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 20930894
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences